RxDoctor Payments Data

Charles Decarli, MD

Neurology · Sacramento, CANPI 1497728083

Payments from drug & device makers

$47,241in general payments, 2019–2025

Across 39 payments — averaging $1211.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$28K
  • Novartis Pharma AG$10K
  • Eisai Inc.$9K
  • Life Molecular Imaging Ltd$14
$8,500in research payments, 2019–2025

Across 3 payments — averaging $2833.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis Pharma AG$9K

What the payments were for

  • Consulting fees$31,36066%
  • Travel & lodging$14,49031%
  • Food & beverage$1,3913%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk21$28,220
Novartis Pharma AG4$9,654
Eisai Inc.13$9,352
Life Molecular Imaging Ltd1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$47,241 in reported general payments places this provider in the 85th percentile of 1,996 neurology providers in California.

See all neurology providers in California

Medicare billing

Part B allowed, 2024
$3,304
Medicare patients
26
Services billed
41

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Sacramento

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →